Ifrah Financial Services Inc. Lowers Holdings in Zoetis Inc. (NYSE:ZTS)

Ifrah Financial Services Inc. reduced its position in Zoetis Inc. (NYSE:ZTS) by 4.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,490 shares of the company’s stock after selling 120 shares during the period. Ifrah Financial Services Inc.’s holdings in Zoetis were worth $491,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the company. River Street Advisors LLC lifted its position in Zoetis by 3.4% during the 4th quarter. River Street Advisors LLC now owns 1,757 shares of the company’s stock worth $347,000 after acquiring an additional 58 shares in the last quarter. Perigon Wealth Management LLC lifted its position in Zoetis by 0.3% during the 4th quarter. Perigon Wealth Management LLC now owns 23,581 shares of the company’s stock worth $4,654,000 after acquiring an additional 59 shares in the last quarter. Revolve Wealth Partners LLC lifted its position in Zoetis by 5.0% during the 4th quarter. Revolve Wealth Partners LLC now owns 1,281 shares of the company’s stock worth $253,000 after acquiring an additional 61 shares in the last quarter. Ellevest Inc. lifted its position in Zoetis by 2.4% during the 3rd quarter. Ellevest Inc. now owns 2,790 shares of the company’s stock worth $485,000 after acquiring an additional 66 shares in the last quarter. Finally, Atria Wealth Solutions Inc. lifted its position in Zoetis by 0.4% during the 3rd quarter. Atria Wealth Solutions Inc. now owns 15,975 shares of the company’s stock worth $2,779,000 after acquiring an additional 70 shares in the last quarter. 92.80% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on ZTS. Barclays cut their target price on Zoetis from $260.00 to $230.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 23rd. Stifel Nicolaus cut their target price on Zoetis from $195.00 to $180.00 and set a “buy” rating on the stock in a research report on Tuesday. The Goldman Sachs Group upped their target price on Zoetis from $190.00 to $226.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Piper Sandler reaffirmed an “overweight” rating and issued a $195.00 target price (down from $220.00) on shares of Zoetis in a research report on Tuesday, April 16th. Finally, StockNews.com lowered Zoetis from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 20th. Eight investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the company currently has an average rating of “Buy” and an average price target of $216.13.

Zoetis Stock Performance

Shares of NYSE ZTS traded down $0.16 during trading on Friday, reaching $167.07. The stock had a trading volume of 3,007,125 shares, compared to its average volume of 4,607,073. Zoetis Inc. has a one year low of $144.80 and a one year high of $201.92. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.00 and a current ratio of 3.36. The stock has a market cap of $76.41 billion, a PE ratio of 32.19, a P/E/G ratio of 2.62 and a beta of 0.86. The firm’s 50 day moving average price is $168.88 and its two-hundred day moving average price is $178.84.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Thursday, May 2nd. The company reported $1.38 earnings per share for the quarter, beating analysts’ consensus estimates of $1.34 by $0.04. Zoetis had a return on equity of 50.74% and a net margin of 27.38%. The business had revenue of $2.19 billion during the quarter, compared to the consensus estimate of $2.14 billion. During the same period in the previous year, the business earned $1.31 EPS. The business’s quarterly revenue was up 9.5% on a year-over-year basis. On average, research analysts forecast that Zoetis Inc. will post 5.78 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 4th. Investors of record on Friday, April 19th will be paid a dividend of $0.432 per share. The ex-dividend date is Thursday, April 18th. This represents a $1.73 dividend on an annualized basis and a yield of 1.03%. Zoetis’s payout ratio is currently 33.33%.

Insider Buying and Selling

In related news, EVP Roxanne Lagano sold 923 shares of the company’s stock in a transaction on Monday, March 18th. The stock was sold at an average price of $173.33, for a total transaction of $159,983.59. Following the completion of the transaction, the executive vice president now directly owns 15,723 shares in the company, valued at approximately $2,725,267.59. The sale was disclosed in a document filed with the SEC, which is available through this link. Insiders sold a total of 2,209 shares of company stock worth $371,293 in the last three months. 0.16% of the stock is owned by insiders.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.